During the past decade, SLK-Kliniken Heilbronn GmbH Klinikum am Plattenwald conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "SLK-Kliniken Heilbronn GmbH Klinikum am Plattenwald" #1 sponsor was "Abbott Medical Devices" with 2 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Daiichi Sankyo, Inc." with 2 trials sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 2 trials sponsored and "Universitätsklinikum Hamburg-Eppendorf" with 2 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "SLK-Kliniken Heilbronn GmbH Klinikum am Plattenwald" #1 collaborator was "Charite University, Berlin, Germany" with 1 trials as a collaborator, "Daiichi Sankyo Deutschland GmbH" with 1 trials as a collaborator, "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "SLK-Kliniken Heilbronn GmbH Klinikum am Plattenwald" are "Atrial Fibrillation" (2 trials), "Lymphoma" (2 trials), "Heart Failure" (1 trials), "Iron Deficiency" (1 trials) and "Myocardial Infarction" (1 trials). Many other conditions were trialed in "SLK-Kliniken Heilbronn GmbH Klinikum am Plattenwald" in a lesser frequency.

Most popular intervention types in "SLK-Kliniken Heilbronn GmbH Klinikum am Plattenwald" are "Drug" (7 trials), "Biological" (2 trials), "Other" (2 trials), "Radiation" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Edoxaban" (2 trials), "cyclophosphamide" (2 trials), "doxorubicin hydrochloride" (2 trials), "prednisone" (2 trials) and "radiation therapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "SLK-Kliniken Heilbronn GmbH Klinikum am Plattenwald" are 9 trials for "All" genders.

Currently, there are NaN active trials in "SLK-Kliniken Heilbronn GmbH Klinikum am Plattenwald". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in SLK-Kliniken Heilbronn GmbH Klinikum am Plattenwald, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SLK-Kliniken Heilbronn GmbH Klinikum am Plattenwald, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".